To Explore Acquired Resistance to Anti-Egfr Agents in Colorectal Cancer for the Development of Potential Treatment Strategies—Focusing on Met, Her2, Kras G12c and Pik3ca Pathway

2023-08-022024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/711916To Explore Acquired Resistance to Anti-Egfr Agents in Colorectal Cancer for the Development of Potential Treatment Strategies—Focusing on Met, Her2, Kras G12c and Pik3ca Pathway